Dataset. 2022

Myeloid cells and Epigenetic Plasticity: Mechanisms and Implications in Autoimmune and other Inflammatory Processes

CORA.Repositori de Dades de Recerca
doi:10.34810/data568
CORA.Repositori de Dades de Recerca
  • Ballestar Tarin, Esteban
BACKGROUND AND CURRENT STATUS: Myeloid cells are crucial effectors of the innate immune response and essential regulators of adaptive immunity. Myeloid cells are myeloid cells are extremely plastic in that they respond and terminally differentiate into a diversity of into a diversity of functional types, in the blood or in tissues, in response to a variety of growth factors. response to a variety of growth factors, cytokines and pathogenic molecules. This plasticity is also manifested by the subversion of normal differentiation toward the aberrant generation of alternative the aberrant generation of alternative varieties of tolerogenic or immunosuppressive myeloid cells in inflammatory immunosuppressive in inflammatory conditions such as those occurring in autoimmune and autoimmune diseases. autoimmune and autoinflammatory diseases, in the context of infection and in the tumor microenvironment where tumor microenvironment where various inflammatory factors are released [Rodríguez-Ubreva et al. et al., 2017]. The differentiation and activation of myeloid cells requires the fine regulation fine regulation of gene expression [Alvarez-Errico et al. 2015]. This depends on the interaction of a variety of elements, including transcription factors and epigenetic mechanisms. epigenetic mechanisms. Epigenetic mechanisms are largely responsible for the plasticity of myeloid cells under both physiological and exacerbated inflammatory conditions. of exacerbated inflammation. The development of compounds that inhibit epigenetic enzymes epigenetic enzymes provides new therapeutic opportunities for intercepting the connection between extracellular factors and host myeloid cells [Rodriguez-Ubreva et al. al., 2017]. In previous projects, our group has determined the connection between diverse transcriptional factors and epigenetic enzymes that direct methylation changes towards certain genomic regions both under physiological conditions [de la Rica et al. (2013, 2015) Vento-Tormo et al (2016), Garcia-Gómez et al (2017)] as well as aberrant [Vento-Tormo et al (2017)]. OBJECTIVES: 1) to identify the mechanistic connection between different stimuli and the elements that determine the acquisition of specific patterns of epigenetic marks in myeloid cells [Vento-Tormo et al. epigenetic marks in tolerogenic or immunosuppressive myeloid cells; 2) to identify the between different stimuli and the acquisition of epigenetic memory in myeloid cells, such as myeloid cells myeloid cells, such as those of tolerance or trained immunity; 3) determine the methylation profile of myeloid cells, such as those of tolerance or 3) to determine the methylation profile of myeloid cells in three representative rheumatic autoimmune diseases and to establish their relationship to genetic factors; 4) to determine the methylation profile of myeloid cells in three 4) to determine the methylation profile of myeloid cells in representative autoinflammatory diseases and to identify the factors involved in the signaling pathways connected with such epigenetic changes. epigenetic changes.
 
DOI: https://doi.org/10.34810/data568
CORA.Repositori de Dades de Recerca
doi:10.34810/data568

HANDLE: https://doi.org/10.34810/data568
CORA.Repositori de Dades de Recerca
doi:10.34810/data568
 
Ver en: https://doi.org/10.34810/data568
CORA.Repositori de Dades de Recerca
doi:10.34810/data568

CORA.Repositori de Dades de Recerca
doi:10.34810/data568
Dataset. 2022

MYELOID CELLS AND EPIGENETIC PLASTICITY: MECHANISMS AND IMPLICATIONS IN AUTOIMMUNE AND OTHER INFLAMMATORY PROCESSES

CORA.Repositori de Dades de Recerca
  • Ballestar Tarin, Esteban
BACKGROUND AND CURRENT STATUS: Myeloid cells are crucial effectors of the innate immune response and essential regulators of adaptive immunity. Myeloid cells are myeloid cells are extremely plastic in that they respond and terminally differentiate into a diversity of into a diversity of functional types, in the blood or in tissues, in response to a variety of growth factors. response to a variety of growth factors, cytokines and pathogenic molecules. This plasticity is also manifested by the subversion of normal differentiation toward the aberrant generation of alternative the aberrant generation of alternative varieties of tolerogenic or immunosuppressive myeloid cells in inflammatory immunosuppressive in inflammatory conditions such as those occurring in autoimmune and autoimmune diseases. autoimmune and autoinflammatory diseases, in the context of infection and in the tumor microenvironment where tumor microenvironment where various inflammatory factors are released [Rodríguez-Ubreva et al. et al., 2017]. The differentiation and activation of myeloid cells requires the fine regulation fine regulation of gene expression [Alvarez-Errico et al. 2015]. This depends on the interaction of a variety of elements, including transcription factors and epigenetic mechanisms. epigenetic mechanisms. Epigenetic mechanisms are largely responsible for the plasticity of myeloid cells under both physiological and exacerbated inflammatory conditions. of exacerbated inflammation. The development of compounds that inhibit epigenetic enzymes epigenetic enzymes provides new therapeutic opportunities for intercepting the connection between extracellular factors and host myeloid cells [Rodriguez-Ubreva et al. al., 2017]. In previous projects, our group has determined the connection between diverse transcriptional factors and epigenetic enzymes that direct methylation changes towards certain genomic regions both under physiological conditions [de la Rica et al. (2013, 2015) Vento-Tormo et al (2016), Garcia-Gómez et al (2017)] as well as aberrant [Vento-Tormo et al (2017)]. OBJECTIVES: 1) to identify the mechanistic connection between different stimuli and the elements that determine the acquisition of specific patterns of epigenetic marks in myeloid cells [Vento-Tormo et al. epigenetic marks in tolerogenic or immunosuppressive myeloid cells; 2) to identify the between different stimuli and the acquisition of epigenetic memory in myeloid cells, such as myeloid cells myeloid cells, such as those of tolerance or trained immunity; 3) determine the methylation profile of myeloid cells, such as those of tolerance or 3) to determine the methylation profile of myeloid cells in three representative rheumatic autoimmune diseases and to establish their relationship to genetic factors; 4) to determine the methylation profile of myeloid cells in three 4) to determine the methylation profile of myeloid cells in representative autoinflammatory diseases and to identify the factors involved in the signaling pathways connected with such epigenetic changes. epigenetic changes.